CLSA Joins PFID Letters on AMR

This month, the Partnership to Fight Infectious Disease (PFID) requested that CLSA sign on to letters to House Energy & Commerce Health Subcommittee Chairwoman Anna Eshoo (D-Silicon Valley) and Rep. Susan Davis (D-San Diego) encouraging them to consider the severity of antimicrobial resistance (AMR) and legislative action that could help combat the issue.  CLSA has long supported efforts to combat AMR, and in a continuation of efforts to expand the coalition of organizations that CLSA engages with on important issues, we agreed to join 14 other cosigners on the letters.  Both the Eshoo and Davis letters can be found here.

Additionally, AMR is an issue that California Life Sciences Institute (CLSI) has engaged on extensively as well. In fact, CLSI is in its 5th and final year serving as an accelerator for CARB-X, the world’s largest public-private partnership devoted to supporting early development antibacterial R&D. You can learn more about CLSI’s efforts here.